HKU Scholars Hub: Browsing DSpace

Browsing by Author Liu, SHK

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 7 to 26 of 33 < previous next >

Title	Author(s)	Issue Date
Determinants for persistent fibrosis during nucleoside analogue therapy in chronic hepatitis B Proceeding/Conference:Hepatology International	Seto, WKW Cheung, KSM Liu, SHK Fung, JYY Wong, DKH Leung, WK Lai, CL Yuen, RMF	2016
Determinants of persistent significant fibrosis during long-term nucleoside analogue therapy in chronic hepatitis B: an interim analysis Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2016	Seto, WKW Cheung, KS Liu, SHK Fung, JYY Wong, DKH Leung, WK Lai, CL Yuen, RMF	2016
Effective inhibition of cccDNA derived mRNA/viral antigens and tolerability with ARC-520 Proceeding/Conference:Hepatology International	Yuen, RMF Chan, HLY Liu, SHK Given, BD Schluep, T Hamilton, J Lai, CL Locarnini, SA Lau, JYN Ferrari, C Gish, RG	2016
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial Journal:Chest	Hung, FNI To, KKW Chan, JFW Cheng, CCV Liu, SHK Tam, A Chan, TCI Zhang, J Li, PCK Wong, TL Zhang, R Cheung, KSM Leung, W Lau, JYN Fok, M Chen, H Chan, KH Yuen, KY	2017
Feasibility of strategic monitoring in patients with prior HBV exposure undergoing anti-CD20 monoclonal antibody therapy: a prospective observational study Proceeding/Conference:Hepatology	Seto, WKW Mak, LY Liu, SHK Cheung, KS Fung, JYY Wong, DKH Lai, CL Yuen, RMF	2017
First clinical experience with RNA interference [RNAI]-based triple combination therapy in chronic hepatitis B (CHB): JNJ-73763989 (JNJ-3989), JNJ-56136379 (JNJ-6379) and a nucleos(t)ide analogue (NA) Proceeding/Conference:Hepatology	Yuen, RMF Locarnini, S Given, B Schluep, T Hamilton, J Biermer, M Kalmeijer, R Beumont-Mauviel, M Lenz, O Cloherty, G Jackson, K Ferrari, C Lai, CL Liu, SHK Mak, LY Wong, DKH To, WP Ko, KL Gish, RG	2019
Hepatic steatosis via controlled attenuation parameter measurements and diabetes contribute to persistent liver fibrosis in the era of long-term nucleoside analogue therapy for chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Seto, WKW Hui, R Mak, LYL Liu, SHK Cheung, KSM Fung, JYY Wong, DKH Lai, CL Yuen, RMF	2017
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study Journal:Hepatology	Seto, WKW Chan, SYT Hwang, YYG Wong, DKH Fung, JYY Liu, SHK Singh, GHH Lam, YF Lau, EHY Cheung, KSM Lie, AKW Lai, CL Kwong, YL Yuen, RMF	2017
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability Journal:Journal of Gastroenterology	Seto, WKW Cheung, KSM Wong, DKH Huang, FY Fung, JYY Liu, SHK Lai, CL Yuen, RMF	2016
Hepatitis B: treatment choice and monitoring for response and resistance Journal:Expert Review of Gastroenterology and Hepatology	Liu, SHK Seto, WKW Lai, CL Yuen, RMF	2016
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study Journal:Journal of Viral Hepatitis	Hui, RWH Seto, WKW Cheung, KSM Mak, LY Liu, SHK Fung, JYY Wong, DKH Lai, CL Yuen, RMF	2018
Inverse relationship of hepatic steatosis and hepatitis B viremia: results of a matched case control study Proceeding/Conference:Hepatology International	Hui, R Seto, WKW Cheung, KS Mak, LY Liu, SHK Fung, JYY Wong, DKH Lai, CL Yuen, RMF	2017
Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance Journal:Liver International	Seto, WKW Tanaka, Y Wong, DKH Shinkai, N Cheung, KSM Liu, SHK Fung, JYY Lai, CL Yuen, RMF	2016
Longitudinal serologic profiles up to 5 years in hepatitis B surface antigen-negative chronic hepatitis B Proceeding/Conference:Hepatology	Seto, WKW Tanaka, Y Wong, DKH Shinkai, N Cheung, KSM Liu, SHK Fung, JYY Lai, CL Yuen, RMF	2014
Prevention of Post-sphincterotomy Bleeding by Proton Pump Inhibitor: A Prospective Randomized Trial Proceeding/Conference:United European Gastroenterology (UEG) Week	Leung, WK But, YKD Wong, SY Liu, SHK Hung, FNI	2016
Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial Journal:Journal of Digestive Diseases	Leung, WK But, YKD Wong, SY Tong, SM Liu, SHK Cheung, KSM Tsang, HYS Chok, KSH Poon, RTP Hung, FNI	2018
Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen Proceeding/Conference:Journal of Hepatology	Yuen, RMF Liu, SHK Chan, HLY Given, BD Schluep, T Hamilton, J Lai, CL Locarnini, SA Lau, JY Ferrari, C Gish, RG	2017
Real world efficacy and tolerability of direct-acting antiviral for treatment of chronic hepatitis C infection: interim results of a territory-wide study in Hong Kong Proceeding/Conference:Hepatology International	Hui, YT Wong, G Liu, SHK Liu, K Cheung, S Ma, YK But, D Mak, WY Tsang, O Lai, KB Loo, CK Ng, A Lai, MS Chan, CW Lau, JYL Fan, T Hui, AJ Lam, CY Cheung, WI Chan, J Lam, K Lai, LSW Luk, WF Li, MKK Lao, WC Lam, JTW Tsang, S Kung, KN Tong, RKN Chan, YK Chow, WH Cheung, CS To, CT Li, CW Wong, J Tao, WL Chan, WS Chan, R Lee, K Yau, W Chan, A Ho, YH Kan, YM Lui, KL Shan, E Fung, JYY Chan, HLY Yuen, RMF Wong, VWS	2018
Rifaximin for the treatment of functional dyspepsia: a double-blinded randomized placebo-controlled trial Proceeding/Conference:Gastroenterology	Tan, VPY Liu, SHK Lam, YF Hung, IFN Leung, WK	2015
RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAg positive and negative patients with chronic HBV Proceeding/Conference:Journal of Hepatology	Yuen, RMF Liu, SHK Given, B Schluep, T Hamilton, J Lai, CL Locarnini, S Jackson, K Lai, JY Ferrari, C Gish, RG.	2018

Showing results 7 to 26 of 33 < previous next >